InChI=1S/C22H30O5/c1- 2- 3- 9- 14- 19(23) 15- 10- 6- 4- 5- 7- 11- 16- 20(24) 21(25) 17- 12- 8- 13- 18- 22(26) 27/h3- 12,15- 16,20- 21,24- 25H,2,13- 14,17- 18H2,1H3,(H,26,27) /b6- 4- ,7- 5+,9- 3- ,12- 8- ,15- 10+,16- 11+/t20- ,21+/m1/s1 |
UKRCOMRGFCFHQM-VPHBCXEASA-N |
C(\CCC(O)=O)=C\C[C@@H]([C@@H](\C=C\C=C\C=C/C=C/C(C/C=C\CC)=O)O)O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
(via resolvin )
|
|
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
(via resolvin )
|
|
View more via ChEBI Ontology
(4Z,7S,8R,9E,11E,13Z,15E,19Z)- 7,8- dihydroxy- 17- oxodocosa- 4,9,11,13,15,19- hexaenoic acid
|
17- oxo- (7S,8R)- dihydroxy- (4Z,9E,11E,13Z,15E,19Z)- docosahexaenoic acid
|
ChEBI
|
17-oxo-7S,8R-dihydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic acid
|
LIPID MAPS
|
17-oxo-RvD1
|
LIPID MAPS
|
17244615
|
PubMed citation
|
Europe PMC
|
|